Mixed group of people

Equal Access

Equal Access

Prioritize PD for the majority of patients, regardless of age, race or socio-economic background, by offering equal access to treatment options and patient support services.

Patient Candidacy

At least 78% of patients have no absolute medical or social contraindication for PD1

Learn more

Addressing Health Disparities

Opportunity exists to increase the use of PD among African & Hispanic Americans2

Learn more

Related Pages

Next page

Prioritize PD for the majority of ESKD patients

Patient Candidacy
References

  1. Mendelssohn DC, et al. A prospective evaluation of renal replacement therapy modality eligibility. Nephrol Dial Transplant. 2009;24(2):555-561

  2. United States Renal Data System. 2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States: End Stage Renal Disease: Chapter 1. Incidence, Prevalence, Patient Characteristics, and Treatment Modalities. National Institute of Diabetes and Digestive and Kidney Diseases.